Guardian Wealth Management (Illinois)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,205
Closed -$55.9K 156
2025
Q1
$55.9K Buy
2,205
+9
+0.4% +$236 0.04% 99
2024
Q4
$58.3K Buy
2,196
+9
+0.4% +$244 0.04% 110
2024
Q3
$63.3K Buy
2,187
+8
+0.4% +$233 0.04% 106
2024
Q2
$61K Buy
2,179
+8
+0.4% +$220 0.05% 105
2024
Q1
$60.2K Sell
2,171
-76
-3% -$2.11K 0.05% 106
2023
Q4
$64.7K Buy
2,247
+1,597
+246% +$48.3K 0.05% 101
2023
Q3
$21.6K Sell
650
-608
-48% -$21.5K 0.02% 133
2023
Q2
$46.2K Buy
1,258
+5
+0.4% +$195 0.04% 106
2023
Q1
$51.1K Buy
1,253
+2
+0.2% +$86 0.05% 106
2022
Q4
$64.1K Buy
1,251
+4
+0.3% +$192 0.06% 106
2022
Q3
$55K Sell
1,247
-73
-6% -$3.55K 0.06% 100
2022
Q2
$69K Buy
1,320
+1
+0.1% +$51 0.07% 99
2022
Q1
$68K Buy
1,319
+6
+0.5% +$311 0.07% 106
2021
Q4
$78K Buy
+1,313
New +$65.1K 0.08% 97

Other funds holding PFE

Guardian Wealth Management (Illinois)'s PFE Position: Q2 2025 in Review

Guardian Wealth Management (Illinois) sold out of Pfizer (PFE) in Q2 2025, closing a stake of 2,205 shares — an estimated $55.9K sold.

Guardian Wealth Management (Illinois) first reported a position in PFE in Q4 2021 and held it in 14 quarters. The position peaked at $78K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Guardian Wealth Management (Illinois) reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Guardian Wealth Management (Illinois) sold 2,205 Pfizer shares in Q2 2025, an estimated $55.9K.
  • Guardian Wealth Management (Illinois) first reported a position in Pfizer in Q4 2021 and held it in 14 quarters.
  • Guardian Wealth Management (Illinois)'s Pfizer position peaked at $78K in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2025, filed 14 Aug 2025.